Endoscopic therapies for Barrett’s-associated dysplasia: a new paradigm for a new decade

References

• Anderson LA, Murray LJ, Murphy SJ et al. Mortality in Barrett’s oesophagus: results from a population based study. Gut 52(8), 1081–1084 (2003).
   PubMed Web of Science ®Google Scholar
• Gopal DV, Lieberman DA, Magaret N et al. Risk factors for dysplasia in patients with Barrett’s esophagus (BE): results from a multicenter consortium. Dig. Dis. Sci. 48(8), 1537–1541 (2003).
   PubMedGoogle Scholar
• Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 119(2), 333–338 (2000).
   PubMed Web of Science ®Google Scholar
• Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am. J. Epidemiol. 168(3), 237–249 (2008).
   PubMed Web of Science ®Google Scholar
• Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 8(3), 235–244; quiz e32 (2010).
   PubMed Web of Science ®Google Scholar
• Desai TK, Krishnan K, Samala N et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut doi:gutjnl-2011-300730 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Riddell RH, Odze RD. Definition of Barrett’s esophagus: time for a rethink – is intestinal metaplasia dead? Am. J. Gastroenterol. 104(10), 2588–2594 (2009).
   PubMedGoogle Scholar
• Kariv R, Plesec TP, Goldblum JR et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin. Gastroenterol. Hepatol. 7(6), 653–658; quiz 606 (2009).
   PubMed Web of Science ®Google Scholar
• Prasad GA, Bansal A, Sharma P, Wang KK. Predictors of progression in Barrett’s esophagus: current knowledge and future directions. Am. J. Gastroenterol. 105(7), 1490–1502 (2010).
   PubMedGoogle Scholar
• Badreddine RJ, Prasad GA, Wang KK et al. Prevalence and predictors of recurrent neoplasia after ablation of Barrett’s esophagus. Gastrointest. Endosc. 71(4), 697–703 (2010).
   PubMedGoogle Scholar
• Peters FP, Curvers WL, Rosmolen WD et al. Surveillance history of endoscopically treated patients with early Barrett’s neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Dis. Esophagus 21(6), 475–479 (2008).
   PubMed Web of Science ®Google Scholar
• Wang KK, Sampliner RE; Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am. J. Gastroenterol. 103(3), 788–797 (2008).
   PubMed Web of Science ®Google Scholar
• Menon D, Stafinski T, Wu H, Lau D, Wong C. Endoscopic treatments for Barrett’s esophagus: a systematic review of safety and effectiveness compared to esophagectomy. BMC Gastroenterol. 10, 111 (2010).
   PubMed Web of Science ®Google Scholar
• Gaddam S, Muthusamy R, Sharma P. The controversy regarding ablation for Barrett’s esophagus without dysplasia. Curr. Opin. Gastroenterol. 27(4), 368–373 (2011).
   PubMedGoogle Scholar
• Gilbert EW, Luna RA, Harrison VL, Hunter JG. Barrett’s esophagus: a review of the literature. J. Gastrointest. Surg. 15(5), 708–718 (2011).
   PubMedGoogle Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 140(3), 1084–1091 (2011).
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96(5 Pt 1), 1249–1256 (1989).
   PubMed Web of Science ®Google Scholar
• Wani S, Falk GW, Post J et al. Risk factors for progression of low-grade dysplasia in patients with Barrett’s esophagus. Gastroenterology 141(4), 1179–1186, 1186.e1 (2011).
   PubMedGoogle Scholar
• Ferguson MK, Naunheim KS. Resection for Barrett’s mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J. Thorac. Cardiovasc. Surg. 114(5), 824–829 (1997).
   PubMedGoogle Scholar
• Shaheen NJ, Inadomi JM, Overholt BF, Sharma P. What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis. Gut 53(12), 1736–1744 (2004).
   PubMed Web of Science ®Google Scholar
• Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagus. Gastrointest. Endosc. 62(1), 16–23 (2005).
   PubMed Web of Science ®Google Scholar
• Tschanz ER. Do 40% of patients resected for barrett esophagus with high-grade dysplasia have unsuspected adenocarcinoma? Arch. Pathol. Lab. Med. 129(2), 177–180 (2005).
   PubMed Web of Science ®Google Scholar
• Konda VJ, Ross AS, Ferguson MK et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett’s esophagus overestimated? Clin. Gastroenterol. Hepatol. 6(2), 159–164 (2008).
   PubMed Web of Science ®Google Scholar
• Chang LC, Oelschlager BK, Quiroga E et al. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett’s esophagus. J. Gastrointest. Surg. 10(3), 341–346 (2006).
   PubMedGoogle Scholar
• Prasad GA, Wang KK, Buttar NS et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 132(4), 1226–1233 (2007).
   PubMed Web of Science ®Google Scholar
• Hoppo T, Jobe BA, Hunter JG. Minimally invasive esophagectomy: the evolution and technique of minimally invasive surgery for esophageal cancer. World J. Surg. 35(7), 1454–1463 (2011).
   PubMedGoogle Scholar
• Nealis TB, Washington K, Keswani RN. Endoscopic therapy of esophageal premalignancy and early malignancy. J. Natl Compr. Canc. Netw. 9(8), 890–899 (2011).
   PubMedGoogle Scholar
• Komanduri S, Deprez PH, Atasoy A et al. Barrett’s esophagus: treatments of adenocarcinomas I. Ann. NY Acad. Sci. 1232, 248–264 (2011).
   PubMed Web of Science ®Google Scholar
• Repaka A, Chak A. Endoscopic management of Barrett esophagus. Nat. Rev. Gastroenterol. Hepatol. 8(10), 582–591 (2011).
   PubMedGoogle Scholar
• Abrams JA, Kapel RC, Lindberg GM et al. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clin. Gastroenterol. Hepatol. 7(7), 736–742; quiz 710 (2009).
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology 140(3), e18–52; quiz e13 (2011).
   PubMed Web of Science ®Google Scholar
• Montgomery E, Bronner MP, Goldblum JR et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum. Pathol. 32(4), 368–378 (2001).
   PubMed Web of Science ®Google Scholar
• Cruz-Correa M, Gross CP, Canto MI et al. The impact of practice guidelines in the management of Barrett esophagus: a national prospective cohort study of physicians. Arch. Intern. Med. 161(21), 2588–2595 (2001).
   PubMedGoogle Scholar
• Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N. Screening and surveillance for Barrett esophagus in high-risk groups: a cost–utility analysis. Ann. Intern. Med. 138(3), 176–186 (2003).
   PubMed Web of Science ®Google Scholar
• Rex DK, Cummings OW, Shaw M et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125(6), 1670–1677 (2003).
   PubMed Web of Science ®Google Scholar
• Sharma P, McQuaid K, Dent J et al.; AGA Chicago Workshop. A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology 127(1), 310–330 (2004).
   PubMed Web of Science ®Google Scholar
• Odze RD. Diagnosis and grading of dysplasia in Barrett’s oesophagus. J. Clin. Pathol. 59(10), 1029–1038 (2006).
   PubMed Web of Science ®Google Scholar
• Wolfsen HC, Crook JE, Krishna M et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s esophagus. Gastroenterology 135(1), 24–31 (2008).
   PubMed Web of Science ®Google Scholar
• Herrero LA, Curvers WL, Bansal A et al. Zooming in on Barrett oesophagus using narrow-band imaging: an international observer agreement study. Eur. J. Gastroenterol. Hepatol. 21(9), 1068–1075 (2009).
   PubMed Web of Science ®Google Scholar
• Wani S, Falk G, Hall M et al. Patients with nondysplastic Barrett’s esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin. Gastroenterol. Hepatol. 9(3), 220–227; quiz e26 (2011).
   PubMed Web of Science ®Google Scholar
• Sharma P, Meining AR, Coron E et al. Real-time increased detection of neoplastic tissue in Barrett’s esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest. Endosc. 74(3), 465–472 (2011).
   PubMed Web of Science ®Google Scholar
• Pohl J, Pech O, May A, Manner H, Fissler-Eckhoff A, Ell C. Incidence of macroscopically occult neoplasias in Barrett’s esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging? Am. J. Gastroenterol. 105(11), 2350–2356 (2010).
   PubMedGoogle Scholar
• Pohl J, May A, Rabenstein T et al. Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett’s esophagus. Endoscopy 39(7), 594–598 (2007).
   PubMedGoogle Scholar
• Curvers WL, van Vilsteren FG, Baak LC et al. Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett’s neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointest. Endosc. 73(2), 195–203 (2011).
   PubMed Web of Science ®Google Scholar
• Aminalai A, Rösch T, Aschenbeck J et al. Live image processing does not increase adenoma detection rate during colonoscopy: a randomized comparison between FICE and conventional imaging (Berlin Colonoscopy Project 5, BECOP-5). Am. J. Gastroenterol. 105(11), 2383–2388 (2010).
   PubMed Web of Science ®Google Scholar
• Atkinson M, Chak A. I-Scan: chromoendoscopy without the hassle? Dig. Liver Dis. 42(1), 18–19 (2010).
   PubMedGoogle Scholar
• Sharma P, Wani S, Weston AP et al. A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 55(9), 1233–1239 (2006).
   PubMed Web of Science ®Google Scholar
• Chennat J, Waxman I. Endoscopic treatment of Barrett’s esophagus: from metaplasia to intramucosal carcinoma. World J. Gastroenterol. 16(30), 3780–3785 (2010).
   PubMedGoogle Scholar
• Madisch A, Miehlke S, Bayerdorffer E et al. Long-term follow-up after complete ablation of Barrett’s esophagus with argon plasma coagulation. World J. Gastroenterol. 11(8), 1182–1186 (2005).
   PubMed Web of Science ®Google Scholar
• Allison H, Banchs MA, Bonis PA, Guelrud M. Long-term remission of nondysplastic Barrett’s esophagus after multipolar electrocoagulation ablation: report of 139 patients with 10 years of follow-up. Gastrointest. Endosc. 73(4), 651–658 (2011).
   PubMedGoogle Scholar
• Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus. Gastrointest. Endosc. 52(3), 328–332 (2000).
   PubMed Web of Science ®Google Scholar
• Namasivayam V, Wang KK, Prasad GA. Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions. Clin. Gastroenterol. Hepatol. 8(9), 743–754; quiz e96 (2010).
   PubMedGoogle Scholar
• Pech O, Behrens A, May A et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9), 1200–1206 (2008).
   PubMed Web of Science ®Google Scholar
• Young PE, Gentry AB, Acosta RD, Greenwald BD, Riddle M. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin. Gastroenterol. Hepatol. 8(12), 1037–1041 (2010).
   PubMed Web of Science ®Google Scholar
• Bhat YM, Furth EE, Brensinger CM, Ginsberg GG. Endoscopic resection with ligation using a multi-band mucosectomy system in Barrett’s esophagus with high-grade dysplasia and intramucosal carcinoma. Therap. Adv. Gastroenterol. 2(6), 323–330 (2009).
   PubMedGoogle Scholar
• Alvarez Herrero L, Pouw RE, van Vilsteren FG et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 43(3), 177–183 (2011).
   PubMedGoogle Scholar
• Peters FP, Kara MA, Curvers WL et al. Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls. Eur. J. Gastroenterol. Hepatol. 19(4), 311–315 (2007).
   PubMed Web of Science ®Google Scholar
• Wani S, Mathur SC, Curvers WL et al. Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett’s dysplasia. Clin. Gastroenterol. Hepatol. 8(9), 783–788 (2010).
   PubMed Web of Science ®Google Scholar
• Peters FP, Krishnadath KK, Rygiel AM et al. Stepwise radical endoscopic resection of the complete Barrett’s esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities. Am. J. Gastroenterol. 102(9), 1853–1861 (2007).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Peters FP, Sempoux C, Piessevaux H, Deprez PH. Stepwise radical endoscopic resection for Barrett’s esophagus with early neoplasia: report on a Brussels’ cohort. Endoscopy 40(11), 892–898 (2008).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Seewald S, Gondrie JJ et al. Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut 59(9), 1169–1177 (2010).
   PubMed Web of Science ®Google Scholar
• van Vilsteren FG, Pouw RE, Seewald S et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 60(6), 765–773 (2011).
   PubMed Web of Science ®Google Scholar
• Chennat J, Konda VJ, Ross AS et al. Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma – an American single-center experience. Am. J. Gastroenterol. 104(11), 2684–2692 (2009).
   PubMed Web of Science ®Google Scholar
• Overholt B, Panjehpour M, Tefftellar E, Rose M. Photodynamic therapy for treatment of early adenocarcinoma in Barrett’s esophagus. Gastrointest. Endosc. 39(1), 73–76 (1993).
   PubMed Web of Science ®Google Scholar
• Overholt BF. Results of photodynamic therapy in Barrett’s esophagus: a review. Can. J. Gastroenterol. 13(5), 393–396 (1999).
   PubMedGoogle Scholar
• Overholt BF, Panjehpour M. Photodynamic therapy for Barrett’s esophagus: clinical update. Am. J. Gastroenterol. 91(9), 1719–1723 (1996).
   PubMed Web of Science ®Google Scholar
• Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest. Endosc. 58(2), 183–188 (2003).
   PubMed Web of Science ®Google Scholar
• Overholt BF, Wang KK, Burdick JS et al.; International Photodynamic Group for High-Grade Dysplasia in Barrett’s Esophagus. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest. Endosc. 66(3), 460–468 (2007).
   PubMed Web of Science ®Google Scholar
• Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Lutzke LS, Borkenhagen LS. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. Gastrointest. Endosc. 65(1), 60–66 (2007).
   PubMed Web of Science ®Google Scholar
• Mackenzie GD, Jamieson NF, Novelli MR et al. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett’s esophagus. Lasers Med. Sci. 23(2), 203–210 (2008).
   PubMed Web of Science ®Google Scholar
• Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest. Endosc. 60(6), 1002–1010 (2004).
   PubMedGoogle Scholar
• Dunkin BJ, Martinez J, Bejarano PA et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg. Endosc. 20(1), 125–130 (2006).
   PubMed Web of Science ®Google Scholar
• Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest. Endosc. 68(5), 867–876 (2008).
   PubMed Web of Science ®Google Scholar
• Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest. Endosc. 65(2), 185–195 (2007).
   PubMed Web of Science ®Google Scholar
• Ganz RA, Overholt BF, Sharma VK et al.; U.S. Multicenter Registry. Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest. Endosc. 68(1), 35–40 (2008).
   PubMed Web of Science ®Google Scholar
• Beaumont H, Gondrie JJ, McMahon BP et al. Stepwise radiofrequency ablation of Barrett’s esophagus preserves esophageal inner diameter, compliance, and motility. Endoscopy 41(1), 2–8 (2009).
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N. Engl. J. Med. 360(22), 2277–2288 (2009).
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Overholt BF, Sampliner RE et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology 141(2), 460–468 (2011).
   PubMed Web of Science ®Google Scholar
• Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 42(10), 781–789 (2010).
   PubMed Web of Science ®Google Scholar
• Boger PC, Turner D, Roderick P, Patel P. A UK-based cost–utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett’s oesophagus. Aliment. Pharmacol. Ther. 32(11–12), 1332–1342 (2010).
   PubMed Web of Science ®Google Scholar
• Vaccaro BJ, Gonzalez S, Poneros JM et al. Detection of intestinal metaplasia after successful eradication of Barrett’s esophagus with radiofrequency ablation. Dig. Dis. Sci. 56(7), 1996–2000 (2011).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Gondrie JJ, Sondermeijer CM et al. Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J. Gastrointest. Surg. 12(10), 1627–1636; discussion 1636 (2008).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Wirths K, Eisendrath P et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin. Gastroenterol. Hepatol. 8(1), 23–29 (2010).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Gondrie JJ, Rygiel AM et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett’s esophagus containing neoplasia. Am. J. Gastroenterol. 104(6), 1366–1373 (2009).
   PubMed Web of Science ®Google Scholar
• Greenwald BD, Dumot JA, Horwhat JD, Lightdale CJ, Abrams JA. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis. Esophagus 23(1), 13–19 (2010).
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Greenwald BD, Peery AF et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest. Endosc. 71(4), 680–685 (2010).
   PubMed Web of Science ®Google Scholar
• Xue HB, Tan HH, Liu WZ et al. A pilot study of endoscopic spray cryotherapy by pressurized carbon dioxide gas for Barrett’s esophagus. Endoscopy 43(5), 379–385 (2011).
   PubMedGoogle Scholar
• Hudson M, Lin CL, Habr F. Current state of endoscopic therapies in Barrett’s esophagus and esophageal cancer. Hosp. Pract. 39(1), 170–180 (2011).
   Google Scholar
• Dumot JA, Vargo JJ 2nd, Falk GW, Frey L, Lopez R, Rice TW. An open-label, prospective trial of cryospray ablation for Barrett’s esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest. Endosc. 70(4), 635–644 (2009).
   PubMed Web of Science ®Google Scholar
• Manner H, May A, Faerber M, Rabenstein T, Ell C. Safety and efficacy of a new high power argon plasma coagulation system (hp-APC) in lesions of the upper gastrointestinal tract. Dig. Liver Dis. 38(7), 471–478 (2006).
   PubMedGoogle Scholar
• Dunn JM, Banks MR, Oukrif D et al. Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett’s esophagus after failed photodynamic therapy. Endoscopy 43(7), 627–630 (2011).
   PubMed Web of Science ®Google Scholar
• Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett’s esophagus: a systematic review. Am. J. Gastroenterol. 106(11), 1899–1908; quiz 1909 (2011).
   PubMed Web of Science ®Google Scholar
• Badreddine RJ, Prasad GA, Wang KK et al. Prevalence and predictors of recurrent neoplasia after ablation of Barrett’s esophagus. Gastrointest. Endosc. 71(4), 697–703 (2010).
   PubMedGoogle Scholar
• Komanduri S, Swanson G, Keefer L, Jakate S. Use of a new jumbo forceps improves tissue acquisition of Barrett’s esophagus surveillance biopsies. Gastrointest. Endosc. 70(6), 1072–1078.e1 (2009).
   PubMedGoogle Scholar
• Shaheen NJ, Peery AF, Overholt BF et al.; AIM Dysplasia Investigators. Biopsy depth after radiofrequency ablation of dysplastic Barrett’s esophagus. Gastrointest. Endosc. 72(3), 490–496.e1 (2010).
   PubMedGoogle Scholar
• Kadri SR, Lao-Sirieix P, O’Donovan M et al. Acceptability and accuracy of a non-ezndoscopic screening test for Barrett’s oesophagus in primary care: cohort study. BMJ 341, c4372 (2010).
   PubMedGoogle Scholar
• Hirota WK, Zuckerman MJ, Adler DG et al.; Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest. Endosc. 63(4), 570–580 (2006).
   PubMed Web of Science ®Google Scholar